| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787551 | Journal of Thoracic Oncology | 2018 | 8 Pages |
Abstract
Dual EGFR blockade with afatinib and cetuximab may induce tumor responses in patients with EGFR exon 20 insertion-positive NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Bianca MD, Adrianus J. MD, PhD, Sayed M.S. MD, Kim MD, PhD, Daniëlle A.M. MD, PhD, Erik MD, PhD, Egbert F. MD, PhD,